Scancell Holdings appoints Dr. Phil L’Huillier as new CEO
LONDON: Scancell Holdings plc (AIM: SCLP), a developer of cancer immunotherapies, has appointed Dr. Phil L’Huillier as the new Chief Executive Officer, effective November 18, 2024. Dr. L’Huillier, previously CEO of CatalYm GmbH, brings extensive experience in expanding investor bases…